Island Pharmaceuticals Future Growth
Future criteria checks 0/6
Island Pharmaceuticals is forecast to grow earnings at 4.1% per annum. EPS is expected to grow by 40.9% per annum.
Key information
4.1%
Earnings growth rate
40.9%
EPS growth rate
| Pharmaceuticals earnings growth | 47.8% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 19 Aug 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 6/30/2024 | 1 | -3 | -3 | -3 | N/A |
| 3/31/2024 | 1 | -3 | -3 | -3 | N/A |
| 12/31/2023 | 1 | -2 | -3 | -3 | N/A |
| 9/30/2023 | 0 | -3 | -3 | -3 | N/A |
| 6/30/2023 | N/A | -3 | -3 | -3 | N/A |
| 3/31/2023 | N/A | -3 | -3 | -3 | N/A |
| 12/31/2022 | N/A | -3 | -2 | -2 | N/A |
| 9/30/2022 | N/A | -3 | -2 | -2 | N/A |
| 6/30/2022 | N/A | -3 | -2 | -2 | N/A |
| 3/31/2022 | N/A | -3 | -2 | -2 | N/A |
| 12/31/2021 | N/A | -3 | -2 | -2 | N/A |
| 9/30/2021 | N/A | -3 | -1 | -1 | N/A |
| 6/30/2021 | N/A | -2 | -1 | -1 | N/A |
| 6/30/2020 | N/A | 0 | N/A | N/A | N/A |
| 12/31/2019 | N/A | -1 | -1 | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ILA is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: ILA is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: ILA is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: Insufficient data to determine if ILA's revenue is forecast to grow faster than the Australian market.
High Growth Revenue: Insufficient data to determine if ILA's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ILA's Return on Equity is forecast to be high in 3 years time